Skip to main content

Table 5 Prognostic impact of triglyceride-glucose index after propensity score matching

From: The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease

Outcome

No. (%)

Unadjusted

Multivariable Adjusted

 ≤ 8.99

 > 8.99

HR (95% CI)

P value

HR (95% CI)

P value

MACE

44 (16.6)

67 (25.3)

1.60 (1.10–2.34)

0.015

1.70 (1.15–2.50)

0.007

All-cause death

33 (12.5)

49 (18.5)

1.52 (0.98–2.37)

0.061

1.66 (1.06–2.59)

0.027

Non-fatal myocardial infarction

8 (3.0)

16 (6.0)

2.10 (0.90–4.91)

0.086

2.05 (0.88–4.81)

0.097

Non-fatal stroke

3 (1.1)

5 (1.9)

1.72 (0.41–7.21)

0.456

1.53 (0.36–6.47)

0.564

Gastrointestinal bleeding

11 (4.2)

14 (5.3)

1.30 (0.59–2.86)

0.516

1.24 (0.56–2.73)

0.599

  1. CI, confidence interval; HR, hazard ratio; MACE, major adverse cardiovascular events